Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Zacks

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiVerizon Rises 9.6% YTD: Should You Add VZ Stock to Your Portfolio Now?
MiCarvana Anticipates Margin Improvement: What's Driving the Growth?
MiLumen Stock Soars on Powering the JUNO Trans-Pacific Cable System
MiMLTX Stock Gains 18% as Merck Reportedly Eyes Buyout
MiIs ExxonMobil's Plan for $35 Oil Breakeven Going to be a Game Changer?
MiHow Walmart's Physical Stores Are Powering Its Digital Expansion
MiHere's Why Hold Strategy is Apt for Xylem Stock Right Now
MiWynn Resorts Stock Jumps 6% in a Month: Should You Buy or Hold?
Mi3M Structural Reorganization Actions in Motion: Will It Boost Margins?
MiIs Boeing's Growth Still Shackled by Continued Problems in Its 737 Program?
MiONEOK Announces Full Ownership of Delaware Basin JV for $940M
MiNIO's Q1 Loss Wider Than Expected, Revenues Increase Y/Y
MiCOF to Face Lawsuit Over Alleged Theft of Influencer Commissions
MiIs TJX's 5% Drop Post Q1 Earnings a Caution or Opportunity?
MiWill Rivian's Charging Update Help It Catch Up With Rivals?
MiOllie's Bargain Q1 Earnings Top Estimates, Comps Up 2.6% Y/Y
MiBEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy
MiD-Wave Quantum Stock Skyrockets on Real-World Computing Breakthroughs
MiGM vs. TM: How Do These Legacy Giants Stack Up in the Auto Space?
MiShould You Buy, Hold or Sell Costco Stock After Q3 Earnings?
MiSNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease
MiRTX Wins $536M Deal to Support US Navy's SPY-6 Family of Radars
MiEni & Shell to Cease Gas Plant Development in Kazakhstan Amid Disputes
MiBP & Partners Greenlight $2.9 Billion Shah Deniz Gas Field Expansion
MiMFC Hits 52-Week High: Time to Hold Despite Expensive Valuation?